Irisin as an Exerkine of Neuroprotection in Aging and Alzheimer’s Disease
Biomolecules · 06.05.2026 · 16 (5) · 687
DOI: 10.3390/biom16050687 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 06.05.2026. Verfasst von Zachary J White und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Fibronectins, Aging, Neuroprotection. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of General Medical Sciences.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a neurodegenerative disease impacting over 6 million Americans, with cases projected to increase to over 14 million by 2060. The AD pathology leads to difficulty completing everyday tasks or conversations, and ultimately, progresses to disrupt the most basic bodily functions and require full-time caretaking. While disease-modifying therapy remains elusive, reducing the incidence of AD is crucial to mitigate the projected increase in cases. Exercise has emerged as an effective strategy to promote brain health in late adulthood and to protect against the onset of AD. Exercise opposes several disease processes, including cognitive dysfunction, amyloid beta aggregation, tau phosphorylation, and deficits in hippocampal volume, mitochondrial function, cerebral blood flow, and neurogenesis, through various pathways, including the systemic release of exerkines. The exerkine irisin is an important mediator of the beneficial relationship between exercise and the brain. Previous work administering irisin therapeutically to healthy and preclinical AD mice has demonstrated irisin use to replicate multiple exercise-induced effects in the brain and protect against AD-induced deficits. Although irisin is suggested as a promising strategy for promoting brain health in late adulthood, our understanding of irisin signaling and its protective effects against AD remains incomplete. This review will investigate irisin as an important, physiologically relevant promoter of brain health in aging and AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA.
ORCID-Profile: Zachary J White
Förderung
- National Institute of General Medical Sciences
Zitieren
APA
White, Z. J., & Hall, S. E. (2026). Irisin as an Exerkine of Neuroprotection in Aging and Alzheimer’s Disease. Biomolecules, 16(5), 687. https://doi.org/10.3390/biom16050687
Vancouver
White ZJ, Hall SE. Irisin as an Exerkine of Neuroprotection in Aging and Alzheimer’s Disease. Biomolecules. 2026;16(5):687. doi:10.3390/biom16050687
BibTeX
@article{White2026,
author = {White, Zachary J and Hall, Stephanie E},
title = {Irisin as an Exerkine of Neuroprotection in Aging and Alzheimer’s Disease},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {5},
pages = {687},
doi = {10.3390/biom16050687}
}
EUVIMED